Clinical Trial Update: Preventing Levodopa Induced Dyskinesia in Parkinson's Disease With HMG-CoA Reductase Inhibitors

View source ↗

Summary

A completed clinical trial examining whether HMG-CoA reductase inhibitors (statins) can prevent levodopa-induced dyskinesia in Parkinson disease, with trial res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyskinesia Drug-induced
• Parkinson Disease

Drugs mentioned

• HMG-CoA reductase inhibitors (statins) (statin)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Parkinson Disease, Dyskinesia, Drug-Induced | Status: COMPLETED | Results posted: 2025-04-11